Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic ...

In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...
Zacks Small Cap Research on MSN

LEXX: DehydraTECH formulation reduces GLP-1 agonist side effects

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) announced results from its Phase Ib ...

Google might let you adjust the name of your Gmail address, at last

Google is experimenting with a long-awaited Gmail feature that could finally let users change their email address name, ...
Newspoint on MSN

Passport: What is the online method for updating the address in your passport, and what things should you keep in mind?

Often, we have to change our address for one reason or another. In such cases, people tend to postpone updating their address ...